Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Lindholm

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 26, 2017
Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Giovanna Sarno, Bo Lagerqvist, Göran Olivecrona, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2018
Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty RegistrySergio Buccheri, Giovanna Sarno, Bo Lagerqvist, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 21, 2017
Timing of percutaneous coronary intervention in patients with non-ST-elevation myocardial infarction: a SWEDEHEART studyDaniel Lindholm, Joakim Alfredsson, Oskar Angerås, et al.
European Heart Journal|May 13, 2019
Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish Coronary and Angioplasty Registry (SCAAR)Sergio Buccheri, Stefan James, Daniel Lindholm, et al.
JAMA Cardiology|November 15, 2018
Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker StudyDaniel Lindholm, Stefan K James, Katja Gabrysch, et al.
Diabetes, Obesity & Metabolism|November 28, 2025
SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complicationsJan W Eriksson, Giovanni Fanni, Martin H Lundqvist, et al.
American Heart Journal|June 2, 2015
Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trialMatthijs A Velders, Lars Wallentin, Richard C Becker, et al.
European Heart Journal|April 15, 2014
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trialDaniel Lindholm, Christoph Varenhorst, Christopher P Cannon, et al.
Journal of the American Heart Association|April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingDaniel Lindholm, Emil Hagström, Stefan K James, et al.
Human Molecular Genetics|February 25, 2016
Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndromeÅsa Johansson, Niclas Eriksson, Daniel Lindholm, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 26, 2017
Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Giovanna Sarno, Bo Lagerqvist, Göran Olivecrona, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2018
Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty RegistrySergio Buccheri, Giovanna Sarno, Bo Lagerqvist, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 21, 2017
Timing of percutaneous coronary intervention in patients with non-ST-elevation myocardial infarction: a SWEDEHEART studyDaniel Lindholm, Joakim Alfredsson, Oskar Angerås, et al.
European Heart Journal|May 13, 2019
Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish Coronary and Angioplasty Registry (SCAAR)Sergio Buccheri, Stefan James, Daniel Lindholm, et al.
JAMA Cardiology|November 15, 2018
Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker StudyDaniel Lindholm, Stefan K James, Katja Gabrysch, et al.
Diabetes, Obesity & Metabolism|November 28, 2025
SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complicationsJan W Eriksson, Giovanni Fanni, Martin H Lundqvist, et al.
American Heart Journal|June 2, 2015
Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trialMatthijs A Velders, Lars Wallentin, Richard C Becker, et al.
European Heart Journal|April 15, 2014
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trialDaniel Lindholm, Christoph Varenhorst, Christopher P Cannon, et al.
Journal of the American Heart Association|April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingDaniel Lindholm, Emil Hagström, Stefan K James, et al.
Human Molecular Genetics|February 25, 2016
Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndromeÅsa Johansson, Niclas Eriksson, Daniel Lindholm, et al.
Pageof 8